Dataset from A 24-Week Multicenter, Randomized, Open-Label, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients With Moderate-to-Severe Plaque Psoriasis Who Are Naive to Systemic Treatment With an Extension Period
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007537
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the efficacy of ixekizumab compared to fumaric
acid esters (FAE) and methotrexate (MTX) in participants with moderate-to-severe plaque
psoriasis who are naive to systemic treatment.
创建时间：
2025-02-22
